ScholarIQanswers from OpenAlex

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer

PaperCitations, authors & open-access status

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer have?

ScholarIQcitation count

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer has 76 citations in the OpenAlex counts ScholarIQ stores.

When was New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer published?

ScholarIQyear

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer has 2020 year in the ScholarIQ index.

What is the open-access status of New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer?

ScholarIQoa status

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer has green oa status in the ScholarIQ index.

What is the DOI of New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer?

ScholarIQdoi

The DOI for New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer is on the source record.

What is the PMID of New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer?

ScholarIQpmid

The PMID for New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer is on the source record.

What is the OpenAlex record for New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer?

ScholarIQopenalex

The OpenAlex for New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial